Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
Status:
Terminated
Trial end date:
2016-06-08
Target enrollment:
Participant gender:
Summary
This study will explore the biologic activity of guanabenz in reducing bone turn over in
solid tumor patients with bone metastasis. If successful, this repurposing of an already,
generic drug could benefit patients faster than manufacturing a novel expensive compound.